India's Serum institute starts manufacturing Codagenix's potential Covid-19 vaccine

  • Facebook
  • Twitter
  • Reddit
  • Flipboard
  • Email
  • WhatsApp
Codagenix's potential Covid-19 vaccine
Codagenix's potential Covid-19 vaccine

New Delhi : Codagenix Inc on Tuesday claimed that India's Serum Institute has started manufacturing the potential Covid-19 vaccine and it expects to conduct the first phase of human trials by the end of 2020 in the UK.

Serum Institute, the world's largest vaccine maker by number of doses produced, will develop Codagenix's CDX-005, which is delivered intranasally rather than via injection.

Serum Institute is working on several vaccine candidates for the novel coronavirus - including potentially mass-producing the one from AstraZeneca-Oxford University that has garnered global headlines - as well as developing its own.

More than 150 potential vaccines are being developed and tested globally, with 38 in human trials, and candidates from Moderna Inc, Pfizer Inc and AstraZeneca Plc are already in late-stage trials.